[1] Abdool-Karim .2021 .New SARS-CoV-2 variants - clinical, public health, and vaccine implications. N. Engl. J. Med, 384 : 1866-1868.
[2] Al-Awaida W.,Al-Hourani J.B.,Swedan S.,Nimer R.,Alzoughool F.,Al-Ameer J.H.,Genes J.H. .2021 .Correlates of SARS-CoV-2 variants on deaths, case incidence and case fatality ratio among the continents for the period of 1 December 2020 to 15 March 2021. , 12 : 1061.
[3] Alkhatib M.,Salpini R.,Carioti L.,Ambrosio F.A.,D'Anna S.,Duca L. .2022 .Update on SARSCoV-2 omicron variant of concern and its peculiar mutational profile. Microbiol, : 21.
[4] Berman H.M.,Westbrook J.,Feng Z.,Gilliland G.,Bhat T.N.,Weissig T.N. .2000 .The protein data bank. Nucl. Acids Res, 28 : 235-242.
[5] Chemaitelly H.,Tang P.,Hasan M.R.,Yassine S.,Benslimane H.M.,F.M. H.M. .2021 .Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar. N. Engl. J. Med, : .
[6] Chen J.,Wang R.,Gilby N.B.,Wei G.W. .2022 .Infectivity, vaccine breakthrough, and antibody resistance. J. Chem. Inf. Model, 62 : 412-422.
[7] Elbe S.,Buckland-Merrett G. .2017 .Data, disease and diplomacy: GISAID's innovative contribution to global health. Glob. Chall., 1 : 33-46.
[8] Fontanet A.,Autran B.,Lina B.,Kieny M.P.,Karim S.S.A.,Sridhar D. .2021 .SARS-CoV-2 variants and ending the COVID-19 pandemic. , 6736(21) : 00370-6.
[9] Greaney A.J.,Starr T.N.,Gilchuk P.,Zost S.J.,Binshtein E.,Loes A.N. .2020 .Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition. Cell Host Microbe, 11 : 44-57.
[10] Harvey W.T.,Carabelli A.M.,Jackson B.,Gupta R.K.,Thomson E.C.,Harrison E.M. .2021 .SARSCoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol., 19 : 409-424.
[11] Janik E.,Niemcewicz M.,Podogrocki M.,Majsterek I.,Bijak M. .2021 .The emerging concern and interest SARS-CoV-2 variants. , 10 : 633.
[12] Jogalekar M.P.,Veerabathini A.,Gangadaran P. .2021 .SARS-CoV-2 variants: A double-edged sword?. Exp. Biol. Med, 246 : 1721-1726.
[13] Kamil J.P. .2021 .Virus variants: GISAID policies incentivize surveillance in global south. Nature, 593 : 341-341.
[14] Khan A.,Waris H.,Rafique M.,Suleman M.,Mohammad A.,Ali S.S. .2022 .variant of SARS-CoV-2 binds to the hACE2 receptor more strongly and escapes the antibody response: Insights from structural and simulation data. Int. J. Biol. Macromol, 01 : 438-448.
[15] Luo C.H.,Morris C.P.,Sachithanandham J.,Amadi A.,Gaston D.,Li M. .2021 .Infection with the SARS-CoV-2 delta variant is associated with higher infectious virus loads compared to the alpha variant in both unvaccinated and vaccinated individuals. medRxiv., 08 : .
[16] Mothes W.,Sherer N.M.,Jin J.,Zhong P. .2010 .Virus cell-to-cell transmission. J. Virol., 84 : 10-8368.
[17] Rehman S.,Hayat F.S.,Norin S.,Aziz A.,Rahman S.,Haq N. .2023 .Epitopes determination for Omicron: The Covid-19 new variant. Pakistan J. Zool., 55 : 641-648.
[18] Rodrigues C.H.,Pires D.E.,Ascher D.B. .2018 .DynaMut: Predicting the impact of mutations on protein conformation, flexibility and stability. Nucl. Acids Res, 46 : W350-W355.
[19] Rosenberg E.S.,Dorabawila V.,Easton D.,Bauer D.,Kumar J.,Hoen R. .2021 .. N. Engl. J. Med, : .
[20] Sattentau Q. .2008 .Avoiding the void: Cell to cell spread of human viruses. Nature Rev. Microbiol., : 815-826.
[21] Shafiq A.,Zubair F.,Ambreen A.,Suleman M.,Yousafi Q.,Niazi R.Z. .2022 .Investigation of the binding and dynamic features of A.30 variant revealed higher binding of RBD for hACE2 and escapes the neutralizing antibody: A molecular simulation approach. Comput. Biol. Med, 146 : 105574.
[22] Sharawi S.E. .2023 .Coronavirus disease pandemic and insects: A historical overview. Adv. Anim. Vet, 11 : 928-932.
[23] Singh S. .2009 .Review of Epidata entry and analysis freewares. Indian J. Commun. Med, 34 : 45384-0218.
[24] Tartof S.Y.,Slezak J.M.,Fischer H.,Hong V.,Ackerson B.K.,Ranasinghe O.N. .2021 .-19 vaccine up to 6 months in a large integrated health system in the USA: A retrospective cohort study. Lancet, 6736(21) : 02183-8.
[25] Townsend J.P.,Hassler H.B.,Wang Z.,Miura S.,Singh J.,Kumar S. .2021 .The durability of immunity against reinfection by SARS-CoV-2: A comparative evolutionary study. Lancet Microb, 5247(21) : 00219-6.
[26] Volz E.,Mishra S.,Chand M.,Barrett J.C.,Johnson J.C.,Geidelberg L. .2021 .Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England. Nature, 593 : 266-269.
[27] Wang R.,Chen J.,Hozumi Y.,Yin C.,Wei G.W. .2021 .Emerging vaccine-breakthrough SARSCoV-2 variants. , : 2109.
[28] WHO .2021 .. Update on Omicron., : .
[29] Winger A.,Caspari T. .2021 .The spike of concernthe novel variants of SARS-CoV-2. , 13 : 1002.
[30] Zeng C.,Evans J.P.,King T.,Zheng Y.M.,Oltz E.M.,Whelan S.P.J. .2022 .SARS-CoV-2 spreads through cell to cell transmission. Proc. natl. Acad. Sci, 119 : .
[31] Zeng C.,Evans J.P.,Qu P.,Faraone J.,Zheng Y.M.,Carlin C. .2021 .Neutralization and stability of SARS-CoV-2 omicron variant. , 12 : .